Eli Lilly and Company (NYSE:LLY) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Sept. 8, ...

Eli Lilly and Company (NYSE:LLY) will participate in the Wells Fargo 20th Annual Healthcare Conference on Sept. 5, 2025.

Eli Lilly and Company has confirmed it’s selling its manufacturing site in Branchburg. The decision was made following a ...

Eli Lilly and Company (NYSE:LLY) is one of the best high growth dividend stocks as the company has raised its payouts for 11 years in a row. In addition, the company has never missed a dividend in ...

Eli Lilly and Company (NYSE:LLY) is one of the most frequently discussed pharmaceutical stocks on Cramer’s morning show. Over the course of this year, the CNBC TV host has maintained that the ...

Eli Lilly files lawsuit against Indianapolis-based weight loss company Eli Lilly and Company is filing a lawsuit against Premier Weight Loss, an Indianapolis-based med spa who Lilly says is misleading ...

Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging Apr. 20, 2025 9:00 AM ET Eli Lilly and Company (LLY) Stock, LLY:CA Stock NVO, PFE, LLY:CA NONOF NVON:CA PFE:CA LLY 20 Comments ...

Eli Lilly and Company will invest up to $4 billion in a new Kenosha County facility. The State of Wisconsin will provide up to $100 million in performance-based tax credits.

Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer to submitting ...

It soon was joined by Eli Lilly (LLY -2.37%), selling similar drugs -- the molecule tirzepatide, approved in 2022 under the name Mounjaro for the diabetes indication and approved a year later as ...